News Buzz : BP p.l.c. (NYSE:BP), Halozyme Therapeutics, Inc. (NASDAQ:HALO), General Cable Corp. (NYSE:BGC), Terreno Realty Corp. (NYSE:TRNO), Proofpoint, Inc. (NASDAQ:PFPT)

On Oct 24, BP p.l.c. (NYSE:BP)’s bid for a new trial over causes of the 2010 Gulf of Mexico oil spill should be rejected because the judge didn’t rely on excluded testimony, Halliburton Co. (HAL) said in court papers. BP p.l.c. (NYSE:BP) belongs to Basic Materials sector. Its net profit margin is 3.00% and weekly…

Read More

Investors Watch List : Halozyme Therapeutics, Inc. (NASDAQ:HALO), Yahoo! Inc. (NASDAQ:YHOO), Otter Tail Corporation (NASDAQ:OTTR), Omnicare Inc. (NYSE:OCR), International Business Machines Corporation (NYSE:IBM),

clinical trial of halozyme’s PEGPH20 in combination with modified folfirinox for advanced pancreatic cancer. The company announced that the U.S. Food and Drug Administration or FDA has removed the clinical hold on patient enrollment and dosing of PEGPH20 in SWOG’s ongoing Phase 1b/2 clinical trial (S1313). Halozyme Therapeutics, Inc. (NASDAQ:HALO) belongs to Healthcare sector. Its…

Read More

Active Stocks: Qualstar Corp. (NASDAQ:QBAK), Halozyme Therapeutics (NASDAQ:HALO), Elizabeth Arden (NASDAQ:RDEN), Saga Communications Inc. (NYSEMKT:SGA), Escalera Resources Co. (NASDAQ:ESCR)

On July 31,2014 Qualstar Corp. (NASDAQ:QBAK), a designer and manufacturer of high efficiency power supplies, as well as data security and archive storage solutions, announced today that it has expanded its AC-DC power supply offerings by adding the high-efficiency slim line DIN Rail Power Supplies to its N2Power brand product portfolio.  Qualstar Corp. (NASDAQ:QBAK) belongs…

Read More

Oversold Stocks In News: Halozyme Therapeutics (NASDAQ:HALO), Lumos Networks (NASDAQ:LMOS), Advaxis (NASDAQ:ADXS), Sterling Construction Company (NASDAQ:STRL)

Halozyme Therapeutics, Inc. (NASDAQ:HALO) reported that the U.S. Food and Drug Administration ordered a halt on a study of its drug delivery system in pancreatic cancer patients, barely a week after the company voluntarily stopped the trial. Halozyme Therapeutics, Inc. (NASDAQ:HALO) stock performance was -0.93% in last session and finished the day at $7.42. Traded…

Read More

Biotech Active runners: Arena Pharmaceuticals (NASDAQ:ARNA), Halozyme Therapeutics (NASDAQ:HALO), Gildan Activewear (NYSE:GIL), Ariad Pharmaceuticals (NASDAQ:ARIA)

Sales of the Arena Pharmaceuticals Inc (NASDAQ:ARNA) anti-obesity drug Belviq have closed out the quarter on a positive note. Sales improved throughout the quarter and are pacing well ahead of the previous quarter. Though this week’s sales only take us to March 28th, there is enough here for us to assess the sales activity, project…

Read More